 SOUTH PLAINFIELD, N.J., Dec. 18, 2020 PRNewswire -- PTC Therapeutics, Inc. NASDAQ: PTCT today announced that on December 15, 2020 it approved non-statutory stock options to purchase an aggregate of 12,500 shares of its common stock and 4,360 restricted stock units RSUs, each... 